|
1
|
Picardo M, Dell'Anna ML, Ezzedine K,
Hamzavi I, Harris JE, Parsad D and Taieb A: Vitiligo. Nat Rev Dis
Primers. 1:150112015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shen C, Gao J, Sheng Y, Dou J, Zhou F,
Zheng X, Ko R, Tang X, Zhu C, Yin X, et al: Genetic susceptibility
to vitiligo: GWAS approaches for identifying vitiligo
susceptibility genes and loci. Front Genet. 7:32016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sandoval-Cruz M, García-Carrasco M,
Sánchez-Porras R, Mendoza-Pinto C, Jiménez-Hernández M,
Munguía-Realpozo P and Ruiz-Argüelles A: Immunopathogenesis of
vitiligo. Autoimmun Rev. 10:762–765. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schallreuter KU, Bahadoran P, Picardo M,
Slominski A, Elassiuty YE, Kemp EH, Giachino C, Liu JB, Luiten RM,
Lambe T, et al: Vitiligo pathogenesis: Autoimmune disease, genetic
defect, excessive reactive oxygen species, calcium imbalance, or
what else? Exp Dermatol. 17:139–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Richmond JM, Frisoli ML and Harris JE:
Innate immune mechanisms in vitiligo: Danger from within. Curr Opin
Immunol. 25:676–682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kingo K, Aunin E, Karelson M, Philips MA,
Rätsep R, Silm H, Vasar E, Soomets U and Kõks S: Gene expression
analysis of melanocortin system in vitiligo. J Dermatol Sci.
48:113–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rousseau K, Kauser S, Pritchard LE,
Warhurst A, Oliver RL, Slominski A, Wei ET, Thody AJ, Tobin DJ and
White A: Proopiomelanocortin (POMC), the ACTH/melanocortin
precursor, is secreted by human epidermal keratinocytes and
melanocytes and stimulates melanogenesis. FASEB J. 21:1844–1856.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Slominski A, Wortsman J, Luger T, Paus R
and Solomon S: Corticotropin releasing hormone and
proopiomelanocortin involvement in the cutaneous response to
stress. Physiol Rev. 80:979–1020. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Y: Structure, function and regulation
of the melanocortin receptors. Eur J Pharmacol. 660:125–130. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Millington GW: Proopiomelanocortin (POMC):
The cutaneous roles of its melanocortin products and receptors.
Clin Exp Dermatol. 31:407–412. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamaguchi Y, Brenner M and Hearing VJ: The
regulation of skin pigmentation. J Biol Chem. 282:27557–27561.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wolf Horrell EM, Boulanger MC and D'Orazio
JA: Melanocortin 1 receptor: Structure, function, and regulation.
Front Genet. 7:952016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tafreshi N, Tichacek CJ, Pandya DN,
Doligalski ML, Budzevich MM, Kil H, Bhatt NB, Kock ND, Messina JL,
Ruiz EE, et al: Melanocortin 1 receptor targeted α-particle therapy
for metastatic Uveal melanoma. J Nucl Med. 60:1124–1133. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zubair R, Lyons AB, Vellaichamy G, Peacock
A and Hamzavi I: What's new in pigmentary disorders. Dermatol Clin.
37:175–181. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
García-Borrón J, Abdel-Malek Z and
Jiménez-Cervantes C: MC1R, the cAMP pathway, and the response to
solar UV: Extending the horizon beyond pigmentation. Pigment Cell
Melanoma Res. 27:699–720. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vázquez-Martínez OT, Velásquez-Arenas L,
Méndez-Olvera N and Ocampo-Candiani J: Vitiligo. Overview and
current therapeutics. DCMQ. 3:2006.
|
|
17
|
Majid I: Vitiligo management: An update.
BJMP. 3:62010.
|
|
18
|
Carsberg CJ, Warenius HM and Friedmann PS:
Ultraviolet radiation-induced melanogenesis in human melanocytes.
Effects of modulating protein kinase C. J Cell Sci. 107:2591–2597.
1994.PubMed/NCBI
|
|
19
|
Fitzpatrick TB: The validity and
practicality of sun-reactive skin types I through VI. Arch
Dermatol. 124:869–871. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stinco G, Trevisan G, Buligan C, Gregoraci
G, De Marchi S, di Meo N and Patrone P: Narrow band-ultraviolet B
versus clobetasol propionate foam in the treatment of vitiligo: A
retrospective study. Dermatol Ther (Heidelb). 3:95–105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Slominski AT, Zmijewski MA, Plonka PM,
Szaflarski JP and Paus R: How UV light touches the brain and
endocrine system through skin, and why. Endocrinology.
159:1992–2007. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Costin GE and Hearing VJ: Human skin
pigmentation: Melanocytes modulate skin color in response to
stress. FASEB J. 21:976–994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Gerstein M and Snyder M: RNA-Seq:
A revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Salinas-Santander M, Trevino V, De la
Rosa-Moreno E, Verduzco-Garza B, Sanchez-Dominguez CN,
Cantu-Salinas C, Ocampo-Garza J, Lagos-Rodríguez A, Ocampo-Candiani
J and Ortiz-López R: CAPN3, DCT, MLANA and TYRP1 are overexpressed
in skin of vitiligo vulgaris Mexican patients. Exp Ther Med.
15:2804–2811. 2018.PubMed/NCBI
|
|
25
|
Swope VB and Abdel-Malek ZA: MC1R: Front
and center in the bright side of dark eumelanin and DNA repair. Int
J Mol Sci. 19(pii): E26672018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wolf Horrell EM, Boulanger MC and D'Orazio
JA: Melanocortin 1 receptor: Structure, function and regulation.
Front Genet. 7:952016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nasti T and Timares L: MC1R, eumelanin and
pheomelanin: Their role in determining the susceptibility to skin
cancer. Photochem Photobiol. 91:188–200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hernando B, Sanz-Page E, Pitarch G,
Mahiques L, Valcuende-Cavero F and Martinez-Cadenas C: Genetic
variants associated with skin photosensitivity in a southern
European population from Spain. Photodermatol Photoimmunol
Photomed. 34:415–422. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beaumont KA, Newton RA, Smit DJ, Leonard
JH, Stow JL and Sturm RA: Altered cell surface expression of human
MC1R variant receptor alleles associated with red hair and skin
cancer risk. Hum Mol Genet. 14:2145–2154. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nagui NA, Mahmoud SB, Abdel Hay RM,
Hassieb MM and Rashed LA: Assessment of gene expression levels of
proopiomelanocortin (POMC) and melanocortin-1 receptor (MC1R) in
vitiligo. Australas J Dermatol. 58:e36–e39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
You P, Hu H, Chen Y, Zhao Y, Yang Y, Wang
T, Xing R, Shao Y, Zhang W, Li D, et al: Effects of melanocortin 3
and 4 receptor deficiency on energy homeostasis in rats. Sci Rep.
6:349382016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Subba K, Karn D and Khatri R:
Triiodothyronin, thyroxine and thyrotropin in vitiligo. Kathmandu
Univ Med J (KUMJ). 9:7–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arıcan Ö, Şaşmaz S and Çetinkaya A: Role
of thyroid hormones in vitiligo type and progression. Turkderm.
37:269–273. 2003.
|
|
34
|
van Beek N, Bodó E, Kromminga A, Gáspár E,
Meyer K, Zmijewski MA, Slominski A, Wenzel BE and Paus R: Thyroid
hormones directly alter human hair follicle functions: Anagen
prolongation and stimulation of both hair matrix keratinocyte
proliferation and hair pigmentation. J Clin Endocrinol Metab.
93:4381–4388. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gupta Y and Ammini AC: Vitiligo,
hypothyroidism and cardiomyopathy. Indian J Endocrinol Metab.
16:463–465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kasumagic-Halilovic E, Prohic A, Begovic B
and Ovcina-Kurtovic N: Association between vitiligo and thyroid
autoimmunity. J Thyroid Res. 2011:9382572011. View Article : Google Scholar : PubMed/NCBI
|
